×
For best experience we recommend to activate Javascript in your browser.
RAG2 antibody (AA 428-527)
The Mouse Monoclonal anti-RAG2 antibody (Clone 2G8) (ABIN519621) specifically detects RAG2 in WB and ELISA.
The antibody is reactive with Human samples.
Catalog No. ABIN519621
$442.13
$520.15
save $78.02 (-15 %)
Plus shipping costs $50.00
Delivery in 11 to 12 Business Days
Quick Overview for RAG2 antibody (AA 428-527) (ABIN519621)
Target
See all RAG2 Antibodies
RAG2
(Recombination Activating Gene 2 (RAG2))
Reactivity
All reactivities for RAG2 antibodies
Human
Host
All hosts for RAG2 antibodies
Mouse
Clonality
All clonalities for RAG2 antibodies
Monoclonal
Conjugate
All conjugates for RAG2 antibodies
This RAG2 antibody is un-conjugated
Application
All applications for RAG2 antibodies
Western Blotting (WB), ELISA
Clone
2G8
Product Details anti-RAG2 Antibody
(hide)
Binding Specificity
All epitopes for RAG2 antibodies
AA 428-527
Purpose
Mouse monoclonal antibody raised against a partial recombinant RAG2.
Sequence
NTWVPFYSTE LNKPAMIYCS HGDGHWVHAQ CMDLAERTLI HLSAGSNKYY CNEHVEIARA LHTPQRVLPL KKPPMKSLRK KGSGKILTPA KKSFLRRLFD
Cross-Reactivity
Human, Rat
Characteristics
Antibody Reactive Against Recombinant Protein.
Immunogen
RAG2 (NP_000527.1, 428 a.a. ~ 527 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.
Isotype
IgG2b
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Buffer
In 1x PBS, pH 7.4
Handling Advice
Aliquot to avoid repeated freezing and thawing.
Storage
-20 °C
Storage Comment
Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.
Target Details for RAG2
(hide)
Target
RAG2
(Recombination Activating Gene 2 (RAG2))
Alternative Name
RAG2
Background
Full Gene Name: recombination activating gene 2 Synonyms: RAG-2
Gene ID
5897
NCBI Accession
NM_000536
Pathways
Chromatin Binding , Production of Molecular Mediator of Immune Response
Recently viewed
(hide)
Chat with us , powered by LiveChat